Terms: = Bone cancer AND LDH AND Prognosis
191 results:
1. [The Value of Baseline PET/CT Imaging of bone Marrow
Wang Y; Zhao M; Yuan L; Li J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):439-444. PubMed ID: 38660849
[TBL] [Abstract] [Full Text] [Related]
2. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
3. Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T-cell lymphoma.
Shen Z; Chen X; Sun C; Lu T; Shi Y; Zhang H; Ye J; Wang L; Zhu T; Miao Y; Zhang X; Wang L; Cai G; Sang W
Cancer Med; 2023 Dec; 12(23):21138-21147. PubMed ID: 37902266
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of the incidence, characteristics, and risk factors of complications during induction chemotherapy in children with high-risk neuroblastoma.
Du J; Yuan X
Eur J Pediatr; 2024 Jan; 183(1):185-202. PubMed ID: 37855927
[TBL] [Abstract] [Full Text] [Related]
5. Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanoma.
Beypınar I; Sözel Y; Önder AH
Cancer Biomark; 2023; 38(3):367-377. PubMed ID: 37718781
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical features and prognostic factors of elderly patients with mantle cell lymphoma].
Hao XY; Yang P; Zhang W; Liu H; Sun XH; Xiao XB; Wang JW; Li ZL; Li LH; Wang SY; He J; Li XL; Jing HM
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):495-500. PubMed ID: 37550206
[No Abstract] [Full Text] [Related]
7. Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China.
Zhang C; Wu H; Xu G; Xu Y; Ma W; Li Z; Zhang J
BMC Cancer; 2023 Jun; 23(1):506. PubMed ID: 37271825
[TBL] [Abstract] [Full Text] [Related]
8. Response rates of extra-nodal diffuse large B cell lymphoma to anti-CD19-CAR T cells: A real word retrospective multicenter study.
Beyar Katz O; Perry C; Grisariu-Greenzaid S; Yehudai-Ofir D; Luttwak E; Avni B; Zuckerman T; Sdayoor I; Stepensky P; Ringelstein-Harlev S; Bar-On Y; Libster D; Sharvit L; Amit O; Greenbaum U; Gold R; Herishanu Y; Benyamini N; Avivi I; Ram R
Eur J Haematol; 2023 Jul; 111(1):63-71. PubMed ID: 36964939
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics and outcomes of follicular lymphoma patients with extranodal involvement: analysis of a series of 1090 cases in China.
Lin Z; Zha J; Yi S; Li Z; Ping L; He X; Fan L; Yu H; Zheng Z; Xu W; Chen F; Xie Y; Chen B; Zhang H; Wang L; Ding K; Li W; Yang H; Zhao W; Qiu L; Li Z; Song Y; Xu B
Clin Transl Oncol; 2023 Jun; 25(6):1821-1829. PubMed ID: 36808598
[TBL] [Abstract] [Full Text] [Related]
10. [OVERALL SURVIVAL EVALUATION OF PROSTATE cancer PATIENTS TREATED WITH ANDROGEN DEPRIVATION THERAPY BY ESTIMATING FLUCTUANT PATTERNS OF METABOLIC FACTOR SERUM LEVELS].
Shimabukuro T; Ohmi C; Baba C; Shiraishi K
Nihon Hinyokika Gakkai Zasshi; 2022; 113(1):1-11. PubMed ID: 36682805
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive analysis of clinicalf eatures, treatment options, overall survival, and prognostic factors in lymphoma cell leukemia patients: A retrospective study.
Kang Y; Fang K; Wang M
J Cancer Res Ther; 2022 Dec; 18(7):1961-1966. PubMed ID: 36647956
[TBL] [Abstract] [Full Text] [Related]
12. Follicular lymphoma: 2023 update on diagnosis and management.
Jacobsen E
Am J Hematol; 2022 Dec; 97(12):1638-1651. PubMed ID: 36255040
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathologic Characteristics Associated with prognosis in Ocular Extranodal Marginal Zone B Cell Lymphoma.
Choi S; Seo M; Park SH; Jo JC; Chae SW; Lee JH; Cha HJ
Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744081
[No Abstract] [Full Text] [Related]
14. Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
Dimitriou F; Namikawa K; Reijers ILM; Buchbinder EI; Soon JA; Zaremba A; Teterycz P; Mooradian MJ; Armstrong E; Nakamura Y; Vitale MG; Tran LE; Bai X; Allayous C; Provent-Roy S; Indini A; Bhave P; Farid M; Kähler KC; Mehmi I; Atkinson V; Klein O; Stonesifer CJ; Zaman F; Haydon A; Carvajal RD; Hamid O; Dummer R; Hauschild A; Carlino MS; Mandala M; Robert C; Lebbe C; Guo J; Johnson DB; Ascierto PA; Shoushtari AN; Sullivan RJ; Cybulska-Stopa B; Rutkowski P; Zimmer L; Sandhu S; Blank CU; Lo SN; Menzies AM; Long GV
Ann Oncol; 2022 Sep; 33(9):968-980. PubMed ID: 35716907
[TBL] [Abstract] [Full Text] [Related]
15. The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide.
Poteska R; Rahbar K; Semjonow A; Schrader AJ; Boegemann M; Schlack K
BMC Cancer; 2022 Apr; 22(1):375. PubMed ID: 35395766
[TBL] [Abstract] [Full Text] [Related]
16. Burkitt lymphoma - no impact of HIV status on outcomes with rituximab-based chemoimmunotherapy.
Tan JY; Qiu TY; Chiang J; Tan YH; Yang VS; Chang EWY; Poon E; Somasundaram N; Farid M; Tao M; Lim ST; Chan JY
Leuk Lymphoma; 2023 Mar; 64(3):586-596. PubMed ID: 35188049
[TBL] [Abstract] [Full Text] [Related]
17. MYCN amplification plus 1p36 loss of heterozygosity predicts ultra high risk in bone marrow metastatic neuroblastoma.
Yue ZX; Xing TY; Zhao W; Zhao Q; Wang XS; Su Y; Gao C; Liu SG; Ma XL
Cancer Med; 2022 Apr; 11(8):1837-1849. PubMed ID: 35137546
[TBL] [Abstract] [Full Text] [Related]
18. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience.
Lee S; Shim HS; Ahn BC; Lim SM; Kim HR; Cho BC; Hong MH
Cancer Immunol Immunother; 2022 May; 71(5):1093-1101. PubMed ID: 34568975
[TBL] [Abstract] [Full Text] [Related]
20. Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis.
Lang M; Feng Y; Meng X; Zhao J; Song Z; Qian Z; Qiu L; Zhou S; Liu X; Li L; Yang H; Song Y; Li W; Zhang H
Hematol Oncol; 2023 Apr; 41(2):239-247. PubMed ID: 34564882
[TBL] [Abstract] [Full Text] [Related]
[Next]
